Literature DB >> 3982641

Long survival of primary cerebral lymphoma with progressive radiation necrosis.

M P Merchut, C Haberland, M H Naheedy, F A Rubino.   

Abstract

A 56-year-old man lived 8 years after excision and irradiation of a primary cerebral lymphoma. Delayed radiation necrosis caused progressive neurologic deterioration and probably his steroid-responsive episodes of obtundation. Vasogenic edema induced by radiation may account for the latter. An incidental extraneural lymphoma was found postmortem without evidence of CNS lymphoma.

Entities:  

Mesh：

Year:  1985        PMID： 3982641     DOI： 10.1212/wnl.35.4.552

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  7 in total

1.  Primary lymphoma of the central nervous system: a diagnostic problem.

Authors:  S Chayasirisobhon; V Kumar; I Ali; C Stiepel
Journal:  J Natl Med Assoc       Date:  1987-02       Impact factor: 1.798

Review 2.  Late radiation necrosis of the brain: case report.

Authors:  R Babu; P P Huang; F Epstein; G N Budzilovich
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

Review 3.  Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy.

Authors:  L M DeAngelis
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

Review 4.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 5.  Primary brain lymphoma. A brief review of clinical aspects and management.

Authors:  K Sharma; N Rastogi; R Srivastva; V K Jain; S Hukku
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

6.  Onset of primary brain T-lymphoma simulating a progressive leukoencephalopathy.

Authors:  L Provinciali; M Signorino; G Ceravolo; U Pasquini
Journal:  Ital J Neurol Sci       Date:  1988-08

7.  Two Cases of Cerebral Involvement in Malignant Lymphoma (CD20+) That Responded to Combination Therapy with Rituximab and Cladribine.

Authors:  Tatsuro Jo; Masatoshi Matsuo; Kensuke Horio; Masao Tomonaga
Journal:  Case Rep Oncol       Date:  2012-05-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.